Randomized contorol trial to determine the Efficacy and Safety on suppression of recurrence after surgery with Dinagest or GnRH for endometriosis.

Trial Profile

Randomized contorol trial to determine the Efficacy and Safety on suppression of recurrence after surgery with Dinagest or GnRH for endometriosis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Jun 2015

At a glance

  • Drugs Dienogest (Primary) ; Gonadotropin releasing hormone
  • Indications Endometriosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Jun 2015 Planned End Date changed from 1 Jan 2012 to 31 Dec 2015 as reported by University Hospital Medical Information Network - Japan.
    • 06 Jun 2015 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 16 Jan 2012 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top